Laboratory Corp. of America Holdings
The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Laboratory Corp. of America Holdings met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded and GAAP earnings per share improved.
Margins dropped across the board.
Laboratory Corp. of America Holdings reported revenue of $1.37 billion. The 21 analysts polled by S&P Capital IQ predicted a top line of $1.38 billion on the same basis. GAAP reported sales were 5.5% higher than the prior-year quarter's $1.30 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Non-GAAP EPS came in at $1.43. The 15 earnings estimates compiled by S&P Capital IQ predicted $1.40 per share on the same basis. GAAP EPS of $1.34 for Q4 were 7.2% higher than the prior-year quarter's $1.25 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 40.2%, 70 basis points worse than the prior-year quarter. Operating margin was 18.9%, 60 basis points worse than the prior-year quarter. Net margin was 9.9%, 30 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $1.41 billion. On the bottom line, the average EPS estimate is $1.57.
Next year's average estimate for revenue is $5.73 billion. The average EPS estimate is $6.52.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 684 members out of 702 rating the stock outperform, and 19 members rating it underperform. Among 240 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 238 give Laboratory Corp. of America Holdings a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Laboratory Corp. of America Holdings is hold, with an average price target of $93.23.
If you're interested in health care stocks like Laboratory Corp. of America Holdings, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add Laboratory Corp. of America Holdings to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of Laboratory of America Holdings. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why LabCorp, comScore, and Atwood Oceanics Slumped Today
These stocks fell in a quiet market. Find out why.
Do Reverse Splits Ever Work?
Some companies seem doomed to failure when they make desperate moves to lift their share prices, but sometimes, reverse splits get the job done.
3 Healthcare Technologies That Are Set to Transform Our Lives Over the Next 10-20 Years
Three Motley Fool analysts discuss game-changing healthcare technologies.